# Application of S26E for Diabetic Foot Ulcer Healing

> **NCT04186377** · PHASE2 · TERMINATED · sponsor: **National and Kapodistrian University of Athens** · enrollment: 5 (actual)

## Conditions studied

- Diabetic Foot
- Neuropathic Foot Ulcer
- Chronic Diabetic Ulcer of Left Foot (Diagnosis)
- Chronic Diabetic Foot Ulcer of Right Foot

## Interventions

- **OTHER:** Standard-of-care for neuropathic/neuroischemic diabetic foot ulcers
- **DRUG:** S26E

## Key facts

- **NCT ID:** NCT04186377
- **Lead sponsor:** National and Kapodistrian University of Athens
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-05-15
- **Primary completion:** 2021-11-29
- **Final completion:** 2021-11-29
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Inability to recruit subjects
- **Last updated:** 2022-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04186377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04186377, "Application of S26E for Diabetic Foot Ulcer Healing". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04186377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*